Evidence map›Paper›PMID 37007481›Full record

ArticleFrontiers in microbiology2023

Production of copropophyrin III, biliverdin and bilirubin by the rufomycin producer,

Gustavo Perez-Ortiz, John D Sidda, Jessica Peate, Davide Ciccarelli, Yaoyu Ding, Sarah M Barry

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. MALDI-TIMS-MSAnalytical chemistry · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gustavo Perez-OrtizDepartment of Chemistry, Faculty of Natural & Mathematical Sciences, King's College London, London, United Kingdom.
John D SiddaDepartment of Chemistry, Faculty of Natural & Mathematical Sciences, King's College London, London, United Kingdom.
Jessica PeateDepartment of Chemistry, Faculty of Natural & Mathematical Sciences, King's College London, London, United Kingdom.
Davide CiccarelliDepartment of Chemistry, Faculty of Natural & Mathematical Sciences, King's College London, London, United Kingdom.
Yaoyu DingDepartment of Chemistry, Faculty of Natural & Mathematical Sciences, King's College London, London, United Kingdom.
Sarah M BarryDepartment of Chemistry, Faculty of Natural & Mathematical Sciences, King's College London, London, United Kingdom.
King's College London · GB

Funding

Medical Research Council MC_PC_14105
6 · The paper itself

Abstract

Heme is best known for its role as a versatile prosthetic group in prokaryotic and eukaryotic proteins with diverse biological functions including gas and electron transport, as well as a wide array of redox chemistry. However, free heme and related tetrapyrroles also have important roles in the cell. In several bacterial strains, heme biosynthetic precursors and degradation products have been proposed to function as signaling molecules, ion chelators, antioxidants and photoprotectants. While the uptake and degradation of heme by bacterial pathogens is well studied, less is understood about the physiological role of these processes and their products in non-pathogenic bacteria.

Indexed as

antioxidanthemenatural product biosynthesisnitric oxidetetrapyrroles

Identifiers

PMID37007481
PMCPMC10060970
OpenAlexW4327616135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.